As shown in Fig 10, BLM treatment can significantly increase the levels of TGF-β1 protein, and phosphorylated Smad2 and Smad3, implying an activation of TGF-β1/Smad2/3 signaling pathway caused by BLM. The gene discussed is BLM; the disease is Bloom syndrome.